| Literature DB >> 29071076 |
Sangita Thapa1, Shishir Gokhale2, Annavarapu Laxminarasimha Sharma3, Lokendra Bahadur Sapkota4, Shamshul Ansari1, Rajendra Gautam1, Sony Shrestha1, Puja Neopane1.
Abstract
INTRODUCTION: Respiratory tract infections are one of the most common human infections in all age group and important cause of mortality and morbidity worldwide. Most bacterial upper respiratory tract infections are vaccine preventable. This study aimed to determine the prevalence of carrier state of bacterial upper respiratory tract pathogens among school children. It also aimed to study their antibiograms.Entities:
Keywords: respiratory infection
Year: 2017 PMID: 29071076 PMCID: PMC5652512 DOI: 10.1136/bmjresp-2017-000203
Source DB: PubMed Journal: BMJ Open Respir Res ISSN: 2052-4439
Age-wise and gender-wise distribution of the study groups
| Age group | Mean age | Median age | Gender | Immunisation status | Hostel status | Total (%) | |||
| M | F | NI | I | NH | H | ||||
| 5–9 years | 6.8±1.19 | 7.0 | 28 | 26 | 6 | 48 | 54 | 0 | 54 (26.47) |
| 10–14 years | 12.12±1.1 | 12.0 | 80 | 70 | 10 | 140 | 98 | 52 | 150 (73.53) |
| Total | 108 (52.9) | 96 (47.1) | 16 (7.84) | 188 (92.16) | 152 (74.5) | 5 (25.4) | 204 (100) | ||
Figures in parenthesis depict %.
F, female; H, hostellers; I, immunised; M, male; NI, non-immunised; NH, non-hostellers.
Samples collected from different age groups from government and private school in summer and winter
| Type of school | Season | Number of sample collected | Total number of | Total number of | |
|---|---|---|---|---|---|
| 5–9 years | 10–14 years | ||||
| Government | Summer | 15 | 37 | 52 | 97 |
| Winter | 16 | 34 | 50 | 115 | |
| Private | Summer | 11 | 39 | 50 | 64 |
| Winter | 12 | 40 | 52 | 118 | |
| Total | 54 | 150 | 204 | 394 | |
Organisms isolated in different age groups
| Organism | Age group | Total (204 samples) | p Value | |
| 5–9 years (54 samples) | 10–14 years (150 samples) | |||
| Viridans streptococci | 43 (79.6) | 117 (78) | 160 (78.4) | 0.82 |
|
| 10 (18.5) | 24 (16) | 34 (16.6) | 0.86 |
|
| 3 (5.5) | 8 (5.3) | 11 (5.3) | 0.99 |
|
| 14 (9.3) | 18 (8.8) | 0.90 | |
|
| 9 (16.6) | 21 (14) | 30 (14.7) | 0.85 |
| Beta-haemolytic streptococci | 2 (3.7) | 5 (3.3) | 7 (3.4) | 0.98 |
|
| 21 (38.8) | 72 (48) | 93 (45.5) | 0.45 |
|
| 2 (3.7) | 1 (0.6) | 3 (1.4) | 0.89 |
|
| 3 (5.5) | 7 (4.6) | 10 (4.9) | 0.95 |
|
| 0 (0) | 3 (2.0) | 3 (1.4) | – |
|
| 0 (0) | 3 (2.0) | 3 (1.4) | – |
|
| 1 (1.8) | 4 (2.6) | 5 (2.4) | 0.96 |
|
| 1 (1.8) | 4 (2.6) | 5 (2.4) | 0.96 |
|
| 2 (1.3) | 7 (3.4) | 0.73 | |
|
| 2 (3.7) | 3 (2.0) | 5 (2.4) | 0.91 |
| Total | 106 | 288 | 394 | |
Figures in parenthesis depict %.
Number and types of organisms isolated with or without repeated throat infection
| Isolates | Number of isolates (N) | Total (204 samples) | p Value | |
| No history of repeated throat infection (112samples) | History of repeated throat infection (92 samples) | |||
| Gram positive bacteria | ||||
| | 86 (76.7) | 74 (80.4) | 160 (78.4) | 0.57 |
| | 6 (5.3) | 28 (30.4) | 34 (16.6) | 0.21 |
| | 2 (1.7) | 9 (8.0) | 11 (5.3) | 0.76 |
| β-haemolytic streptococci (non-Group A) | 8 (7.1) | 10 (8.9) | 18 (8.8) | 0.89 |
| | 6 (5.3) | 24 (21.4) | 30 (14.7) | 0.36 |
| | 2 (1.7) | 5 (4.4) | 7 (3.4) | 0.87 |
| Total | 110 | 150 | 260 | |
| Gram negative bacteria | ||||
| Moraxella spp | 53 (47.3) | 40 (43.4) | 93 (45.5) | 0.71 |
| | 0 (0) | 3 (2.6) | 3 (1.4) | - |
| | 3 (2.6) | 7 (6.2) | 10 (4.9) | 0.82 |
| | 2 (1.7) | 1 (0.8) | 3 (1.4) | 0.95 |
| Enterobacter spp | 2 (1.7) | 1 (0.8) | 3 (1.4) | 0.95 |
| Citrobacter spp | 2 (1.7) | 3 (2.6) | 5 (2.4) | 0.95 |
| Acinetobacter spp | 1 (0.8) | 4 (3.5) | 5 (2.4) | 0.89 |
| | 2 (1.7) | 5 (4.4) | 7 (3.4) | 0.87 |
| | 1 (0.8) | 4 (3.5) | 5 (2.4) | 0.89 |
| Total | 66 | 68 | 134 | |
Figures in parenthesis depict %.
Antibiotic resistance pattern of Gram positive and Gram negative isolates
| Isolates | P | E | CIP | CTR | OX | G | COT | CN | AMP | C | AZM | AMC | AK |
|
| 91.7 | 14.7 | 8.82 | 5.88 | – | – | 38.2 | – | – | 00 | – | – | – |
|
| 00 | 00 | 00 | 00 | – | – | 00 | 00 | – | – | – | – | – |
| β-haemolytic streptococci (non-Group A) (18) | 00 | 00 | 00 | 00 | – | – | 00 | – | 00 | – | – | – | – |
|
| 86.6 | 20 | 13.3 | 10 | 23.3 | – | – | 00 | – | – | – | – | – |
|
| 28.5 | 42.8 | – | 28.5 | – | 00 | – | – | – | – | – | – | – |
|
| – | – | 00 | 20 | 00 | 00 | 30 | 100 | – | – | – | – | |
|
| 100 | 00 | 00 | 00 | 100 | – | 100 | – | – | – | – | ||
| Enterobacter spp (3) | 00 | – | 00 | 33.3 | 00 | 33.3 | 100 | – | – | – | – | ||
| Citrobacter spp (4) | – | 00 | – | 00 | 00 | 100 | 100 | – | – | – | 00 | ||
| Acinetobacter spp (5) | – | 00 | – | 00 | 00 | 100 | 100 | – | – | – | 00 | ||
|
| – | 00 | 00 | – | 100 | – | – | 00 | 00 | 100 | – | ||
|
| – | 00 | 00 | – | 100 | – | – | 00 | 00 | 100 | – | ||
|
| 100 | 00 | 00 | – | 00 | – | – | 00 | – | 00 | – |
Figures in parenthesis depict %.
AK, amikacin; AMC, amoxy-clavulanic acid; AMP, ampicillin; AZM, azithromycin; C, chloramphenicol; CIP, ciprofloxacin; CN, cephalexin; COT, cotrimoxazole; CTR, ceftriaxone; CZ, cefazolin; E, erythromycin; G, gentamicin; OX, oxacillin, P, penicillin; 00, no resistance; –, not tested.